Inhibition of YAP Sensitizes the Selumetinib Treatment for Neurofibromatosis Type 1 Related Plexiform Neurofibroma

Background: Targeted therapy of Neurofibromatosis type 1 (NF1) related plexiform neurofibroma (pNF) aiming at MEK molecule has not demonstrated a convincing result for complete disease inhibition, probably due to other signal pathways crosstalk. Our previous study revealed an increased nuclear trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Zhuowei, You, Yuanhe, Xiao, Meng, Liu, Jialiang, Xu, Guisong, Ma, Chunyue, Du, Zhong, Wang, Yanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812799/
https://www.ncbi.nlm.nih.gov/pubmed/36619222
http://dx.doi.org/10.7150/ijms.78386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812799/
https://www.ncbi.nlm.nih.gov/pubmed/36619222
http://dx.doi.org/10.7150/ijms.78386

Ejemplares similares